journal
Journals Central Nervous System Agents ...

Central Nervous System Agents in Medicinal Chemistry

https://read.qxmd.com/read/38584543/filtration-of-natural-derivatives-as-mao-inhibitors-by-virtual-screening-a-potential-lead-for-neurodegenerative-disorders
#1
JOURNAL ARTICLE
Neelam Malik, Supriya Agnihotri, Priyanka Dhiman
AIM: The purpose of the current study was to explore the virtual library for the screening against Monoamine oxidase (MAO) isoforms. An in-house library of natural based ligands was docked within the active sites of MAO isoforms and their in vitro study was also conducted. OBJECTIVE: The prime objective of the current study was to screen and validate the natural-based derivatives for MAO inhibitory action with the least adverse effects and get molecular aspects about further structural modifications on the most active leads...
April 4, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38551039/current-concepts-in-the-molecular-mechanisms-and-management-of-diabetic-neuropathy-by-pharmacotherapeutics-and-natural-compounds
#2
JOURNAL ARTICLE
Shivam, Asheesh Kumar Gupta, Sushil Kumar
One of the most crippling effects of diabetes mellitus is diabetic neuropathy, which can cause discomfort, loss of movement, and even amputation. Diabetic neuropathy manifests in a variety of ways, ranging from pain to death. Diagnosing diabetic neuropathy can be challenging since it often goes unnoticed for many years following the onset of diabetes. In addition to oxidative stress in neurons, hyperglycemia activates a number of metabolic pathways that are important sources of damage and possible targets for treatment in diabetic neuropathy...
March 28, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38551038/nanomedicine-a-new-frontier-in-alzheimer-s-disease-drug-targeting
#3
JOURNAL ARTICLE
Kalyani Pathak, Mohammad Zaki Ahmad, Riya Saikia, Manash Pratim Pathak, Jon Jyoti Sahariah, Parimita Kalita, Aparoop Das, Md Ariful Islam, Pallab Pramanik, Dubom Tayeng, Basel A Abdel-Wahab
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder affecting elderly individuals, characterized by progressive cognitive decline leading to dementia. This review examines the challenges posed by anatomical and biochemical barriers such as the blood-brain barrier (BBB), blood-cerebrospinal fluid barrier (BCSFB), and p-glycoproteins in delivering effective therapeutic agents to the central nervous system (CNS) for AD treatment. This article outlines the fundamental role of acetylcholinesterase inhibitors (AChEIs) and NMDA(N-Methyl-D-Aspartate) receptor antagonists in conventional AD therapy and highlights their limitations in terms of brain-specific delivery...
March 28, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38551059/exploring-the-diverse-therapeutic-potentials-of-synthetic-analogues-of-keto-terpenoids-carvone-a-future-scaffold
#4
JOURNAL ARTICLE
Snigdha Srivastava, Reema Sinha, Rahul Kaushik, Rajan Kumar Kurmi
BACKGROUND: Carvone is a monoterpene ketone in mint plants and some Mediterranean spices. In Carvone, chemical compounds occur in two enantiomers, S (+) carvone and R (-) carvone. These two enantiomeric forms of carvone are identical in terms of their physical and chemical characteristics and only differ in terms of their rotatory power based on their smell. Caraway has also been utilized to treat newborns' flatulent colic and to treat adults' anxious cardiac- gastric symptoms, spasmodic gastrointestinal complaints, flatulence, irritated stomach, indigestion, lack of appetite, and dyspepsia...
March 27, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38509681/assessing-blood-brain-barrier-function-in-the-context-of-pain-management
#5
JOURNAL ARTICLE
Farshad Hassanzadeh Kiabi, Saeed Gharooee Ahangar, Siavash Beiranvand
One essential component of the neurovascular system is known as the blood-brain barrier (BBB). This highly effective biological barrier plays a pivotal role in regulating the brain's internal microenvironment and carefully controlling the passage of various chemicals into and out of the brain. Notably, it serves as a safeguard for the brain, particularly when it comes to the selective transportation of drugs like opioids and non-steroidal anti-inflammatory medications (NSAIDs), which are commonly used in the management of chronic pain...
March 20, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38468523/resveratrol-protective-agent-against-alzheimer-s-disease
#6
JOURNAL ARTICLE
Iqra Subhan, Yasir Hasan Siddique
Resveratrol is a biologically active natural phenolic plant product. It has several properties which make them useful to treat the disease. In this review, we have highlighted the neuroprotective effects of resveratrol. Several available animal models have been proven to help understand the disease pathway and mechanism of action by resveratrol. In this review, we have highlighted the neuroprotective activity of resveratrol in AD, which effectively counter the neurodegenerative disease by decreasing the formation of plaques...
March 11, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38409725/the-role-of-ocimene-in-decreasing-%C3%AE-synuclein-aggregation-using-rotenone-induced-rat-model
#7
JOURNAL ARTICLE
Ankul Singh S, Aarita Sood, Chitra Vellapandian
BACKGROUND: Parkinson's disease is defined by the loss of dopaminergic neurons in the midbrain of substantia nigra associated with Lewy bodies. The precise mechanism is not yet entirely understood. OBJECTIVE: The study aims to determine whether ocimene has antiparkinsonian activity by reducing α-Synuclein aggregation levels in the brains of rotenone-induced rat models. METHODS: 36 male rats were used for six groups, with six animals in each group...
February 23, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38409724/effectiveness-of-novel-drug-delivery-system-using-curcumin-in-alzheimer-s-disease
#8
JOURNAL ARTICLE
Aswar Urmila, Rathod Kundlik, Dyandevi Mathure
Alzheimer's disease (AD) is a form of brain degeneration that gradually impairs a person's memory and cognitive skills, eventually making it harder for them to perform everyday activities. Its pathophysiology has been attributed to the deposition of amyloid β (Aβ), neurofibrillary tangles (NFT), and α-synuclein (A-s) in some cases. Presently, 4 drugs have been approved for the treatment. They are Donepezil, Rivastigmine, Galantamine and Memantine. The first three are acetylcholinesterase inhibitors, while memantine is an NMDA receptor antagonist...
February 23, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38288823/lead-identification-through-in-silico-studies-targeting-acetylcholinesterase-enzyme-against-alzheimer-s-disease
#9
JOURNAL ARTICLE
Dhairiya Agarwal, Sumit Kumar, Ramesh Ambatwar, Neeru Bhanwala, Lokesh Chandrakar, Gopal Khatik
AIM: In this work, we aimed to acquire the best potential small molecule for Alzheimer's disease (AD) treatment using different models in Biovia Discovery Studio to identify new potential inhibitors of acetylcholinesterase (AChE) via in silico studies. BACKGROUND: The prevalence of cognitive impairment-related neurodegenerative disorders, such as AD, has been observed to escalate rapidly. However, we still know little about the underlying functions, outcome predictors, or intervention targets causing AD...
January 26, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38299298/network-reorganization-for-neurophysiological-and-behavioral-recovery-following-stroke
#10
JOURNAL ARTICLE
Yuan Qi, Yujie Xu, Huailu Wang, Qiujia Wang, Meijie Li, Bo Han, Haijie Liu
<p>Stroke continues to be the main cause of motor disability worldwide. While it has been promised to improve recovery after stroke, efficacy in clinical trials has been mixed. We need to understand the cortical recombination framework to understand how biomarkers for neurophysiological reorganized neurotechnologies alter network activity. Here, we summarize the principles of the movement network, including the current evidence of changes in the connections and function of encephalic regions, recovery from stroke and the therapeutic effects of rehabilitation...
January 25, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38279716/purple-carrot-extract-exhibits-a-neuroprotective-profile-in-the-nigrostriatal-pathway-in-the-reserpine-induced-model-of-parkinson-s-disease
#11
JOURNAL ARTICLE
Ana Claudia Custódio-Silva, Jose Ivo Araújo Beserra-Filho, Beatriz Soares-Silva, Amanda Maria-Macêdo, Suellen Silva-Martins, Sara Pereira Silva, José Ronaldo Santos, Regina Helena Silva, Daniel Araki Ribeiro, Alessandra Mussi Ribeiro
BACKGROUND: Parkinson's disease (PD) is a chronic neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the nigrostriatal pathway. Even with scientific and technological advances, the therapeutic approaches used for the treatment of PD have shown to be largely ineffective in controlling the progression of symptoms in the long term. There is a growing demand for the development of novel therapeutic strategies for PD treatment. Different herbs and supplements have been considered as adjuvant to treat the symptoms of Parkinsonism...
January 25, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38275073/sulfonamide-derivatives-recent-compounds-with-potent-anti-alzheimer-s-disease-activity
#12
JOURNAL ARTICLE
Melford Chuka Egbujor
Facile synthetic procedures and broad spectrum of biological activities are special attributes of sulfonamides. Sulfonamide derivatives have demonstrated potential as a class of compounds for the treatment of Alzheimer's disease (AD). Recent sulfonamide derivatives have been reported as prospective anti-AD agents, with a focus on analogues that significantly inhibit the function of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes and exhibit remarkable antioxidant and anti-inflammatory properties, all of which are critical for the treatment of AD...
January 24, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38265387/bridging-the-mind-and-gut-uncovering-the-intricacies-of-neurotransmitters-neuropeptides-and-their-influence-on-neuropsychiatric-disorders
#13
JOURNAL ARTICLE
Saumya Gupta, Susha Dinesh, Sameer Sharma
BACKGROUND: The gut-brain axis (GBA) is a bidirectional signaling channel that facilitates communication between the gastrointestinal tract and the brain. Recent research on the gut-brain axis demonstrates that this connection enables the brain to influence gut function, which in turn influences the brain and its cognitive functioning. It is well established that malfunctioning of this axis adversely affects both systems' ability to operate effectively. OBJECTIVE: Dysfunctions in the GBA have been associated with disorders of gut motility and permeability, intestinal inflammation, indigestion, constipation, diarrhea, IBS, and IBD, as well as neuropsychiatric and neurodegenerative disorders like depression, anxiety, schizophrenia, autism, Alzheimer's, and Parkinson's disease...
January 23, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38265386/exploring-the-therapeutic-potential-of-phytoconstituents-for-addressing-neurodegenerative-disorders
#14
JOURNAL ARTICLE
Sweta Kamboj, Prerna Sharma, Rohit Kamboj, Shikha Kamboj, Hari Om, Girija, Kumar Guarve, Rohit Dutt, Inderjeet Verma, Kamal Dua, Nidhi Rani
Neurodegenerative disorder is a serious condition that is caused by abnormal or no neurological function. Neurodegenerative disease is a major growing cause of mortality and morbidity worldwide, especially in the elderly. After World War Ⅱ, eugenics term was exterminated from medicines. Neurodegenerative disease is a genetically inherited disease. Lifestyle changes, environmental factors, and genetic modification, together or alone, are involved in the occurrence of this disorder. The major examples of neurodegenerative disorders are Alzheimer's and Parkinson's disease, in which apoptosis and necrosis are the two major death pathways for neurons...
January 23, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38305396/marine-derived-compounds-a-powerful-platform-for-the-treatment-of-alzheimer-s-disease
#15
JOURNAL ARTICLE
Rashmi Arora, Ritchu Babbar, Abhishek Dabra, Bhawna Chopra, Geeta Deswal, Ajmer Singh Grewal
Alzheimer's disease (AD) is a debilitating form of dementia that primarily affects cholinergic neurons in the brain, significantly reducing an individual's capacity for learning and creative skills and ultimately resulting in an inability to carry out even basic daily tasks. As the elderly population is exponentially increasing, the disease has become a significant concern for society. Therefore, neuroprotective substances have garnered considerable interest in addressing this universal issue. Studies have shown that oxidative damage to neurons contributes to the pathophysiological processes underlying AD progression...
January 16, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38305395/effect-of-flavonoids-against-parkinson-s-disease
#16
JOURNAL ARTICLE
Himanshi Varshney, Yasir Hasan Siddique
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is characterized by the depletion of striatal dopamine content and aggregation of alphasynuclein in the substantia nigra (SN). It is possible to treat the symptoms of PD with a variety of medications, but they often result in complications and are not able to cure or stop the progression of the disease. Flavonoids (the phytocomponents present in almost all fruits and vegetables) are the class of secondary metabolites that have generated a peak of interest because of their medicinal properties, including a reduction in the risk of PD...
January 16, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38305394/molecular-pathway-epidemiological-data-and-treatment-strategies-of-fungal-infection-mycoses-a-comprehensive-review
#17
JOURNAL ARTICLE
Namrata Singh, Vibha Kumari, Karan Agrawal, Mayank Kulshreshtha
The recent increase in fungal infections is a health crisis. This surge is directly tied to the increase in immunocompromised people caused by changes in medical practice, such as the use of harsh chemotherapy and immunosuppressive medicines. Immunosuppressive disorders such as HIV have exacerbated the situation dramatically. Subcutaneous or superficial fungal infections can harm the skin, keratinous tissues, and mucous membranes. This category includes some of the most common skin disorders that impact millions of people worldwide...
January 16, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38305392/neuroprotective-effects-of-isolated-mangiferin-from-swertia-chirayita-leaves-regulating-oxidative-pathway-on-streptozotocin-induced-diabetic-neuropathy-in-experimental-rats
#18
JOURNAL ARTICLE
Shivam, Asheesh Kumar Gupta
BACKGROUND: Oxidative stress has an important role in the pathogenesis and development of diabetic peripheral neuropathy (DPN), the most common and debilitating complication of diabetes mellitus. Swertia chirayita is a rich source of phenolic constituents and has hypoglycemic, anti-inflammatory, and antioxidant properties. AIMS: This study was performed to evaluate the neuroprotective effect in diabetes by enhancing antioxidant defense against oxidative stress, which exhibits a neuroprotective effect in streptozotocin- induced diabetic rats...
January 16, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38273763/glutamate-receptors-and-c-abl-inhibitors-a-new-therapeutic-approach-for-parkinson-s-disease
#19
JOURNAL ARTICLE
Priya P Shejul, Gaurav M Doshi
Parkinson's disease (PD) is the second-most prevalent central nervous system (CNS) neurodegenerative condition. Over the past few decades, suppression of BCR-Abelson tyrosine kinase (c-Abl), which serves as a marker of -synuclein aggregation and oxidative stress, has shown promise as a potential therapy target in PD. c-Abl inhibition has the potential to provide neuroprotection against PD, as shown by experimental results and the first-in-human trial, which supports the strategy in bigger clinical trials. Furthermore, glutamate receptors have also been proposed as potential therapeutic targets for the treatment of PD since they facilitate and regulate synaptic neurotransmission throughout the basal ganglia motor system...
January 16, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38305393/a-comprehensive-review-on-potential-molecular-drug-targets-for-the-management-of-alzheimer-s-disease
#20
JOURNAL ARTICLE
Chanchal Sharma, Avijit Mazumder
Alzheimer's disease (AD) is an onset and incurable neurodegenerative disorder that has been linked to various genetic, environmental, and lifestyle factors. Recent research has revealed several potential targets for drug development, such as the prevention of Aβ production and removal, prevention of tau hyperphosphorylation, and keeping neurons alive. Drugs that target numerous ADrelated variables have been developed, and early results are encouraging. This review provides a concise map of the different receptor signaling pathways associated with Alzheimer's Disease, as well as insight into drug design based on these pathways...
January 12, 2024: Central Nervous System Agents in Medicinal Chemistry
journal
journal
41301
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.